Ritalin la and Weight abnormal - a phase IV clinical study of FDA data
Summary:
Weight abnormal is reported as a side effect among people who take Ritalin la (methylphenidate hydrochloride), especially for people who are male, 10-19 old, have been taking the drug for 2 - 5 years also take Xyrem, and have Cataplexy.
The phase IV clinical study analyzes which people have Weight abnormal when taking Ritalin la. It is created by eHealthMe based on reports of 2,254 people who have side effects when taking Ritalin la from the FDA, and is updated regularly.
What is Ritalin la?
Ritalin la has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 2,563 Ritalin la users. Check the latest studies of Ritalin la.
What is Weight abnormal?
Weight abnormal is found to be associated with 1,603 drugs and 1,301 conditions by eHealthMe. Check the latest studies of Weight abnormal.
2,254 people reported to have side effects when taking Ritalin la.
Among them, 14 people (0.62%) have Weight abnormal.

Among these 14 people:
How long have people been on Ritalin la when they have Weight abnormal? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 100 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Weight abnormal when taking Ritalin la? *
- female: 42.86 %
- male: 57.14 %
What is the age of people who have Weight abnormal when taking Ritalin la? *
- 0-1: 0.0 %
- 2-9: 14.29 %
- 10-19: 42.86 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 28.57 %
- 50-59: 14.29 %
- 60+: 0.0 %
What are other drugs people take besides Ritalin la? *
- Xyrem: 6 people, 42.86%
- Ritalin: 2 people, 14.29%
- Fluoxetine: 2 people, 14.29%
- Dexedrine: 2 people, 14.29%
- Myrbetriq: 2 people, 14.29%
- Nuvigil: 2 people, 14.29%
- Oxycodone And Acetaminophen: 2 people, 14.29%
- Oxycontin: 2 people, 14.29%
- Buspar: 2 people, 14.29%
- Roxicodone: 2 people, 14.29%
What are other side effects people have besides Weight abnormal? *
- Weight Increased: 4 people, 28.57%
- Stress And Anxiety: 3 people, 21.43%
- Agitation (state of anxiety or nervous excitement): 3 people, 21.43%
- Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 3 people, 21.43%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 14.29%
- Disturbance In Attention: 2 people, 14.29%
- Diabetes: 2 people, 14.29%
- Nervousness: 2 people, 14.29%
- Psychomotor Hyperactivity (feelings of extreme restlessness): 2 people, 14.29%
- Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 14.29%
What are the existing conditions these people have? *
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 42.86%
- Drowsiness: 2 people, 14.29%
- Disturbance In Attention: 2 people, 14.29%
- Psychomotor Hyperactivity (feelings of extreme restlessness): 1 person, 7.14%
- Memory Loss: 1 person, 7.14%
- Libido Disorder (a sexual dysfunction relating to loss of sexual desire): 1 person, 7.14%
- Educational Problem: 1 person, 7.14%
- Depression: 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Ritalin la and have Weight abnormal?
- Check whether Weight abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ritalin la:
- Ritalin la (2,563 reports)
Weight abnormal treatments and more:
- Weight abnormal (2,837 reports)
How severe was Weight abnormal and when was it recovered:
Expand to all the drugs that have ingredients of methylphenidate hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ritalin la:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Weight abnormal:
- Weight abnormal (1,603 drugs)
Browse all the conditions that are associated with Weight abnormal:
- Weight abnormal (1,301 conditions)
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Ritalin la) and Ritalin la (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamin B12 and Dyspnea for Women aged 30-39 - now
- Vitamin B12 and Dyspnoea for Women aged 30-39 - a second ago
- Could Exidine cause Heart Rate Increased? - a second ago
- Could Metformin cause Fear Of Disease? - 14 seconds ago
- Could Esomeprazole Magnesium cause Tension Headache? - 36 seconds ago
- Accutane and Nausea for Girls aged 10-19 - 43 seconds ago
- Could Gleevec cause Pancreatic Carcinoma? - 46 seconds ago
- Drug interactions of Excedrin and Tylenol W/ Codeine No. 3 - 46 seconds ago
- Chest Pain in Yaela, how severe and when it was recovered? - 52 seconds ago
- Drug interactions of Tamiflu and Metformin Hydrochloride - a minute ago